https://whattonoh.jp/ https://whattonoh.jp/news https://whattonoh.jp/articles https://whattonoh.jp/data https://whattonoh.jp/data/kessan https://whattonoh.jp/data/kaigi https://whattonoh.jp/data/yakka https://whattonoh.jp/data/releases https://whattonoh.jp/data/kaigi/topic/yakka-shusai https://whattonoh.jp/data/kaigi/topic/hiyotaikoka https://whattonoh.jp/contact https://whattonoh.jp/videos https://whattonoh.jp/about https://whattonoh.jp/privacy https://whattonoh.jp/terms https://whattonoh.jp/topics/yakka https://whattonoh.jp/topics/policy https://whattonoh.jp/topics/mfn https://whattonoh.jp/topics/approval https://whattonoh.jp/topics/data https://whattonoh.jp/topics/launch https://whattonoh.jp/topics/earnings https://whattonoh.jp/topics/deal https://whattonoh.jp/topics/obesity https://whattonoh.jp/topics/china https://whattonoh.jp/topics/distribution https://whattonoh.jp/topics/commercial https://whattonoh.jp/topics/digital https://whattonoh.jp/topics/healthcare https://whattonoh.jp/topics/global https://whattonoh.jp/topics/other https://whattonoh.jp/articles/chugai-q3-2026-earnings 2026-10-28 https://whattonoh.jp/articles/takeda-adc-gastric-cancer-3rd-line-os 2026-10-27 https://whattonoh.jp/articles/amgen-tarlatamab-dellphi-305-sclc-2026 2026-10-26 https://whattonoh.jp/articles/alexion-stories-of-silent-days-rare-disease 2026-10-25 https://whattonoh.jp/articles/openevidence-jama-study-2026 2026-10-24 https://whattonoh.jp/articles/icer-2026-launch-price-access-report 2026-10-23 https://whattonoh.jp/articles/adl-regenerative-medicine-policy-proposal-2026 2026-10-22 https://whattonoh.jp/articles/roche-deutschland-investment-hold-gkv-reform 2026-10-21 https://whattonoh.jp/articles/chmp-foundayo-rasonque-october-2026 2026-10-20 https://whattonoh.jp/articles/efpia-drug-loss-policy-reform-2026 2026-10-19 https://whattonoh.jp/articles/stemilac-honshounin-2026 2026-10-17 https://whattonoh.jp/articles/fda-rare-disease-framework-initiative-2026 2026-10-16 https://whattonoh.jp/articles/bms-phase-3-admilparant-ryz101-2026 2026-10-15 https://whattonoh.jp/articles/shinnyaku-11-seibun-yakka-syusai-2026-10 2026-10-13 https://whattonoh.jp/articles/cost-calc-5-drugs-premium-zero 2026-10-08 https://whattonoh.jp/articles/shionogi-intrabio-acquisition 2026-10-07 https://whattonoh.jp/articles/rohto-midterm-plan-upward-revision 2026-10-06 https://whattonoh.jp/articles/ips-heart-sheet-reheart-first-transplant 2026-10-05 https://whattonoh.jp/articles/daiichi-datroway-ivonescimab-p3 2026-10-04 https://whattonoh.jp/articles/toho-hd-phc-acquisition-proposal 2026-10-03 https://whattonoh.jp/articles/cost-effectiveness-price-adjustment-expansion 2026-10-02 https://whattonoh.jp/articles/mhlw-white-paper-2026 2026-10-01 https://whattonoh.jp/articles/mhlw-negative-margin-price-increase 2026-09-30 https://whattonoh.jp/articles/lilly-change-the-course-glp1-lmic 2026-09-29 https://whattonoh.jp/articles/novo-nordisk-2030-strategy-selfpay 2026-09-28 https://whattonoh.jp/articles/pubmed-linked-discoveries 2026-09-27 https://whattonoh.jp/articles/gsk-uk-pmcpa-grossly-misleading 2026-09-26 https://whattonoh.jp/articles/china-first-in-class-quarter-target 2026-09-25 https://whattonoh.jp/articles/otsuka-ionis-fus-als-p3 2026-09-24 https://whattonoh.jp/articles/europe-pharma-chairs-innovation-letter 2026-09-23 https://whattonoh.jp/articles/pfizer-lilly-mfn-agreement-disclosed 2026-09-22 https://whattonoh.jp/articles/akuugo-first-patient-after-2years 2026-09-21 https://whattonoh.jp/articles/fda-pmda-real-time-clinical-trial 2026-09-20 https://whattonoh.jp/articles/fda-ultragenyx-gene-therapy-approval 2026-09-19 https://whattonoh.jp/articles/shionogi-us-xocova-campaign 2026-09-18 https://whattonoh.jp/articles/pharma-groups-cost-effectiveness-freeze 2026-09-17 https://whattonoh.jp/articles/mfn-lancet-model-study 2026-09-16 https://whattonoh.jp/articles/enhertu-lung-first-line-os-negative 2026-09-14 https://whattonoh.jp/articles/ucb-bimzelx-us-tv-ad-top 2026-09-13 https://whattonoh.jp/articles/pmda-project-orbis 2026-09-12 https://whattonoh.jp/articles/chugai-yanagisawa-lasker-award-2026 2026-09-11 https://whattonoh.jp/articles/drug-pricing-earthquake-commercial-report 2026-09-10 https://whattonoh.jp/articles/novartis-three-setbacks-share-drop 2026-09-09 https://whattonoh.jp/articles/novo-ziltivekimab-two-trials-halted 2026-09-08 https://whattonoh.jp/articles/uk-pharma-investment-withdrawal-1year 2026-09-07 https://whattonoh.jp/articles/whitehouse-lilly-medicare-blockbuster 2026-09-06 https://whattonoh.jp/articles/drug-loss-86-products-mhlw-review 2026-09-05 https://whattonoh.jp/articles/silchester-medipal-egm-proposal 2026-09-04 https://whattonoh.jp/articles/mhlw-budget-request-fy2027-36-6cho 2026-09-03 https://whattonoh.jp/articles/orexin-agonist-cns-glp1-competition 2026-09-02 https://whattonoh.jp/articles/mfn-9-more-companies-astellas-kyowa 2026-09-01 https://whattonoh.jp/articles/mhlw-promotion-violation-report-2026 2026-08-31 https://whattonoh.jp/articles/mounjaro-cv-risk-indication-us 2026-08-30 https://whattonoh.jp/articles/iryohi-fy2025-record-49-2cho 2026-08-29 https://whattonoh.jp/articles/revolution-medicines-daraxonrasib-fda 2026-08-28 https://whattonoh.jp/articles/chuikyo-mfn-industry-testimony 2026-08-27 https://whattonoh.jp/articles/daiichi-sankyo-commercialization-unit 2026-08-26 https://whattonoh.jp/articles/switzerland-mfn-reimbursement-withheld 2026-08-25 https://whattonoh.jp/articles/rare-disease-patient-group-reputation-2026 2026-08-24 https://whattonoh.jp/articles/generic-drug-lobby-development-abandonment 2026-08-23 https://whattonoh.jp/articles/whitehouse-mfn-drug-price-drop 2026-08-22 https://whattonoh.jp/articles/moderna-mrna-cancer-vaccine-p3 2026-08-21 https://whattonoh.jp/articles/tanabe-delcimerago-leo-pharma 2026-08-20 https://whattonoh.jp/articles/iqvia-sales-data-trend 2026-08-19 https://whattonoh.jp/articles/argenx-vyvgart-myositis-p23 2026-08-18 https://whattonoh.jp/articles/jmdc-fy26-q1 2026-08-17 https://whattonoh.jp/articles/icer-astrazeneca-hypertension 2026-08-16 https://whattonoh.jp/articles/lilly-retatrutide-illegal-sales-suit 2026-08-15 https://whattonoh.jp/articles/pharma-q2-2026-earnings-rush 2026-08-14 https://whattonoh.jp/articles/revolution-medicines-beone-asia-deal 2026-08-13 https://whattonoh.jp/articles/pharma-tv-ad-spending-july-2026 2026-08-12 https://whattonoh.jp/articles/big-four-wholesalers-fy26-q1-earnings 2026-08-11 https://whattonoh.jp/articles/m3-fy26q1-earnings-decline 2026-08-10 https://whattonoh.jp/articles/pfizer-q2-2026-earnings-25b-cost-cut 2026-08-09 https://whattonoh.jp/articles/novo-vs-lilly-glp1-q2-2026 2026-08-07 https://whattonoh.jp/articles/dupixent-yakkka-saisan-2026 2026-08-06 https://whattonoh.jp/articles/az-bms-merger-bad-idea 2026-08-05 https://whattonoh.jp/articles/lilly-mounjaro-yakka-hikisage-2026 2026-08-04 https://whattonoh.jp/articles/astrazeneca-bms-merger-talks-4000-billion 2026-08-03 https://whattonoh.jp/articles/alnylam-q2-2026-earnings-guidance-cut 2026-08-02 https://whattonoh.jp/articles/abbvie-skyrizi-humira-record-sales 2026-08-01 https://whattonoh.jp/articles/astrazeneca-h1-2026-earnings-oncology 2026-07-31 https://whattonoh.jp/articles/lilly-p3i-ranking-first 2026-07-30 https://whattonoh.jp/articles/gsk-q2-2026-accelerate-growth 2026-07-29 https://whattonoh.jp/articles/ge-biosimilar-vision-2040 2026-07-28 https://whattonoh.jp/articles/chugai-h1-2026-earnings 2026-07-27 https://whattonoh.jp/articles/novo-lilly-glp-1-false-advertising-lawsuit 2026-07-26 https://whattonoh.jp/articles/takeda-obepiorextan-china-first-approval 2026-07-25 https://whattonoh.jp/articles/jma-koutai-2026-3-point-objection 2026-07-24 https://whattonoh.jp/articles/trump-generic-tariff-reshoring-2028 2026-07-23 https://whattonoh.jp/articles/koutai-houshin-2026-ei-kaigi-kettei 2026-07-22 https://whattonoh.jp/articles/nvidia-big-pharma-ai-infrastructure-partnerships 2026-07-21 https://whattonoh.jp/articles/merck-lipfendla-cnpv-approval 2026-07-20 https://whattonoh.jp/articles/lancet-human-security-diplomacy-2040 2026-07-19 https://whattonoh.jp/articles/lancet-2026-japan-uhc-vision-2040 2026-07-18 https://whattonoh.jp/articles/jj-tremfya-stelara-q2-2026 2026-07-17 https://whattonoh.jp/articles/jaskaid-ipf-pff-launch-2026 2026-07-16 https://whattonoh.jp/articles/germany-mandatory-rebates-15-5-percent 2026-07-15 https://whattonoh.jp/articles/souyaku-kanmin-kyogikai-mfn-scenario 2026-07-14 https://whattonoh.jp/articles/glp-1-usage-us-2026-four-fold-increase 2026-07-13 https://whattonoh.jp/articles/mckinsey-ai-drug-discovery-linear-gates-learning-loops 2026-07-12 https://whattonoh.jp/articles/jimin-ishin-shakaihosho-kaikaku-13 2026-07-11 https://whattonoh.jp/articles/astrazeneca-wainua-attr-cm-trial-failure 2026-07-10 https://whattonoh.jp/articles/national-university-hospitals-deficit-2025 2026-07-09 https://whattonoh.jp/articles/cancer-patient-reputation-ranking-2026 2026-07-08 https://whattonoh.jp/articles/oral-glp1-foundayo-vs-wegovy-us 2026-07-07 https://whattonoh.jp/articles/domestic-drug-sales-ranking-2025 2026-07-06 https://whattonoh.jp/articles/tanabe-pharma-fabless-towayakuhin 2026-07-05 https://whattonoh.jp/articles/roche-divarasib-kras-g12c-phase3 2026-07-04 https://whattonoh.jp/articles/car-t-solid-tumor-china-approval-2026 2026-07-03 https://whattonoh.jp/articles/2040-nendo-soshoku-chikara-kyoka-naikakufu 2026-07-02 https://whattonoh.jp/articles/tavneos-nejm-retract-2026 2026-07-01 https://whattonoh.jp/articles/clinical-trials-2026-h2 2026-06-30 https://whattonoh.jp/articles/regenerative-medicine-self-paid-survey-fy2025 2026-06-29 https://whattonoh.jp/articles/nature-medicine-immunotherapy-timing-retraction 2026-06-28 https://whattonoh.jp/articles/global-pharma-market-2-trillion-2032 2026-06-27 https://whattonoh.jp/articles/nihon-seichou-senryaku-souyaku-64chouen 2026-06-26 https://whattonoh.jp/articles/lilly-foundayo-eu-mfn-telehealth 2026-06-25 https://whattonoh.jp/articles/mr-problematic-communication-88-percent 2026-06-24 https://whattonoh.jp/articles/abbvie-apogee-109-billion-acquisition 2026-06-23 https://whattonoh.jp/articles/foreign-executives-higher-pay-than-ceo 2026-06-22 https://whattonoh.jp/articles/moderna-mflusiqa-fda-vrbpac-approval 2026-06-21 https://whattonoh.jp/articles/us-investigates-germany-drug-pricing-ustr-301 2026-06-20 https://whattonoh.jp/articles/takeda-weber-ceo-compensation-evaluation 2026-06-19 https://whattonoh.jp/articles/elevidys-yakka-3oku-yakkan-akaji 2026-06-18 https://whattonoh.jp/articles/takeda-obeplorexton-sleep-2026 2026-06-17 https://whattonoh.jp/articles/japan-korea-research-rankings-2026 2026-06-16 https://whattonoh.jp/articles/us-dtc-ads-ranking-may-2026-immunology 2026-06-15 https://whattonoh.jp/articles/takeda-zasocitinib-head-to-head-tyk2 2026-06-14 https://whattonoh.jp/articles/pwc-us-medical-cost-trend-2027 2026-06-13 https://whattonoh.jp/articles/parabilis-medicines-ipo-6-7-billion 2026-06-12 https://whattonoh.jp/articles/gsk-nuvalent-106-billion-cancer-acquisition 2026-06-11 https://whattonoh.jp/articles/biopharma-ceo-pay-2025-top25 2026-06-10 https://whattonoh.jp/articles/ada-2026-obesity-market-retatrutide-novo 2026-06-09 https://whattonoh.jp/articles/gni-ayumi-acquisition-2026 2026-06-08 https://whattonoh.jp/articles/shionogi-endeavor-ride-adhd-dts-2026 2026-06-07 https://whattonoh.jp/articles/takeda-amitiza-antitrust-verdict-2026 2026-06-06 https://whattonoh.jp/articles/nhk-regenerative-medicine-free-care-2026 2026-06-05 https://whattonoh.jp/articles/roto-avi-torikubigiian-2025 2026-06-04 https://whattonoh.jp/articles/daraxonrasib-asco-2024-pancreatic-cancer 2026-06-02 https://whattonoh.jp/articles/biopharma-ceo-japan-innovation-crisis-2026 2026-06-01 https://whattonoh.jp/articles/glp1-jiyushindairyou-mondai 2026-05-31 https://whattonoh.jp/articles/pfizer-innovent-1-6trn-yen-deal 2026-05-30 https://whattonoh.jp/articles/lilly-vaccine-infectious-disease-reentry-2026 2026-05-29 https://whattonoh.jp/articles/astellas-csp2026-strategic-products 2026-05-28 https://whattonoh.jp/articles/eisai-3l-medium-term-plan-2028 2026-05-27 https://whattonoh.jp/articles/novo-nordisk-ai-india-bangalore-gcc 2026-05-26 https://whattonoh.jp/articles/lilly-retatrutide-p3-triumph-1-2026 2026-05-25 https://whattonoh.jp/articles/tirzepatide-glp1-worldleader-2025 2026-05-24 https://whattonoh.jp/articles/wholesale-distributors-mid-term-strategy 2026-05-23 https://whattonoh.jp/articles/pharma-4-wholesalers-fy2026-results 2026-05-22 https://whattonoh.jp/articles/kissei-tabneos-fda-approval-withdrawal 2026-05-20 https://whattonoh.jp/articles/ips-cell-drug-yakka-2024 2026-05-19 https://whattonoh.jp/articles/glp1-jiyushinryo-kiseikinai 2026-05-18 https://whattonoh.jp/articles/manjaro-yakka-25pct-2026-passs 2026-05-17 https://whattonoh.jp/articles/takeda-fy2025-earnings-webber-ceo 2026-05-16 https://whattonoh.jp/articles/teijin-takeda-diabetes-acquisition-writedown 2026-05-15 https://whattonoh.jp/articles/teijin-2026-healthcare-segment-earnings 2026-05-14 https://whattonoh.jp/articles/daiichisankyo-6ki-chukan-2030 2026-05-13 https://whattonoh.jp/articles/daiichi-sankyo-fy2025-earnings-revision 2026-05-12 https://whattonoh.jp/articles/ono-pharma-2026-fosiega-optivo-cliff 2026-05-11 https://whattonoh.jp/articles/seivisc-meniscus-regenerative-medicine-approval 2026-05-10 https://whattonoh.jp/articles/kyowakirin-q1-2026-earnings-rare-disease 2026-05-09 https://whattonoh.jp/articles/lilly-glp1-market-share-q1-2026 2026-05-08 https://whattonoh.jp/articles/china-bioventure-license-deal-2025 2026-05-07 https://whattonoh.jp/articles/shionogi-8800oku-deal-2025 2026-05-06 https://whattonoh.jp/articles/toho-hd-chuki-keiei-keikaku-2028 2026-05-05 https://whattonoh.jp/articles/vcube-listing-delisting-2026 2026-05-04 https://whattonoh.jp/articles/m3-2025-earnings-ai-strategy 2026-05-03 https://whattonoh.jp/articles/lecanemab-880-oku-2025 2026-05-02 https://whattonoh.jp/articles/astellas-fy2025-earnings-xtandi-patent-cliff 2026-05-01 https://whattonoh.jp/articles/2026-10-27-fronteo 2026-10-27 https://whattonoh.jp/articles/2026-10-27-1-9-core-1-681 2026-10-27 https://whattonoh.jp/articles/2026-10-27-eu-her2-2 2026-10-27 https://whattonoh.jp/articles/2026-10-27-heartseed-hs-005-1 2026-10-27 https://whattonoh.jp/articles/2026-10-27-q3-11 2026-10-27 https://whattonoh.jp/articles/2026-10-27-coartem-baby-who 2026-10-27 https://whattonoh.jp/articles/2026-10-27-nda-vms 2026-10-27 https://whattonoh.jp/articles/2026-10-27-kaisetsu-2 2026-10-27 https://whattonoh.jp/articles/2026-10-27-enzomenib-fda 2026-10-27 https://whattonoh.jp/articles/2026-10-27-1-5 2026-10-27 https://whattonoh.jp/articles/2026-10-27-volga-49 2026-10-27 https://whattonoh.jp/articles/2026-10-27-met-egfr-pfs-os 2026-10-27 https://whattonoh.jp/articles/2026-10-27-cldn18-2-adc-2-42 2026-10-27 https://whattonoh.jp/articles/2026-10-27-b7-h3-adc-iii 2026-10-27 https://whattonoh.jp/articles/2026-10-27-eu-her2 2026-10-27 https://whattonoh.jp/articles/2026-10-26-iii 2026-10-26 https://whattonoh.jp/articles/2026-10-26-cvc-otsuka-bioventures 2026-10-26 https://whattonoh.jp/articles/2026-10-26-bon-001-iii 2026-10-26 https://whattonoh.jp/articles/2026-10-27-3 2026-10-27 https://whattonoh.jp/articles/2026-10-26-cldn18-2-adc-3-os-pfs 2026-10-26 https://whattonoh.jp/articles/2026-10-26-pmda 2026-10-26 https://whattonoh.jp/articles/2026-10-26-iii-2 2026-10-26 https://whattonoh.jp/articles/2026-10-26-nice-gnrh-1-3 2026-10-26 https://whattonoh.jp/articles/2026-10-26-mpgn-c3 2026-10-26 https://whattonoh.jp/articles/2026-10-26-iii-os-17-7 2026-10-26 https://whattonoh.jp/articles/2026-10-26-j-j-orr77 2026-10-26 https://whattonoh.jp/articles/2026-10-26-genmab-2-1l-orr75 2026-10-26 https://whattonoh.jp/articles/2026-10-25-2-nsclc-corr36-7 2026-10-25 https://whattonoh.jp/articles/2026-10-25-gsk-76-azur-1 2026-10-25 https://whattonoh.jp/articles/2026-10-25-j-j-proteus-62 2026-10-25 https://whattonoh.jp/articles/2026-10-25-1-58 2026-10-25 https://whattonoh.jp/articles/2026-10-25-genmab-incyte-kras-g12d 2026-10-25 https://whattonoh.jp/articles/2026-10-24-fda 2026-10-24 https://whattonoh.jp/articles/2026-10-24-ema-ama 2026-10-24 https://whattonoh.jp/articles/2026-10-23-4-digital-84-171 2026-10-23 https://whattonoh.jp/articles/2026-10-23-47 2026-10-23 https://whattonoh.jp/articles/2026-10-23-asp-1929-esmo-2026 2026-10-23 https://whattonoh.jp/articles/2026-10-23-e-projection-mfn 2026-10-23 https://whattonoh.jp/articles/2026-10-24-genmab-rina-s-3-pfs-os 2026-10-24 https://whattonoh.jp/articles/2026-10-24-iga-3-43-1 2026-10-24 https://whattonoh.jp/articles/2026-10-24-j-j-esmo2026-25-riptac 2026-10-24 https://whattonoh.jp/articles/2026-10-24-iii-rms 2026-10-24 https://whattonoh.jp/articles/2026-10-24-kisqali-natalee6 2026-10-24 https://whattonoh.jp/articles/2026-10-23-2026 2026-10-23 https://whattonoh.jp/articles/2026-10-23-nice-mri-ai-5-nhs 2026-10-23 https://whattonoh.jp/articles/2026-10-23-mibc 2026-10-23 https://whattonoh.jp/articles/2026-10-23-2-97-1 2026-10-23 https://whattonoh.jp/articles/2026-10-23-mrna-3-42 2026-10-23 https://whattonoh.jp/articles/2026-10-23-2027-60-15-evaluate-5 2026-10-23 https://whattonoh.jp/articles/2026-10-23-fda-nain 2026-10-23 https://whattonoh.jp/articles/2026-10-23-iii 2026-10-23 https://whattonoh.jp/articles/2026-10-22-enk-direct-qpcr 2026-10-22 https://whattonoh.jp/articles/2026-10-22-vamorolone-2028 2026-10-22 https://whattonoh.jp/articles/2026-10-22-iii-16 2026-10-22 https://whattonoh.jp/articles/2026-10-23-iga-c5 2026-10-23 https://whattonoh.jp/articles/2026-10-22-biken-6-iii 2026-10-22 https://whattonoh.jp/articles/2026-10-23-1-9-24-6 2026-10-23 https://whattonoh.jp/articles/2026-10-23-biontech-tnbc-3-adc 2026-10-23 https://whattonoh.jp/articles/2026-10-23-il-23r-hcxt-2001-12-75 2026-10-23 https://whattonoh.jp/articles/2026-10-23-j-j-acr2026-43-icotyde-psa-3 2026-10-23 https://whattonoh.jp/articles/2026-10-23-j-j-pfa-aphrs-2026-varipulse-pro 2026-10-23 https://whattonoh.jp/articles/2026-10-23-aasld2026-21-pbc-3-ideal 2026-10-23 https://whattonoh.jp/articles/2026-10-22-bcg2026 2026-10-22 https://whattonoh.jp/articles/2026-10-22-3-7-cer-9-25 2026-10-22 https://whattonoh.jp/articles/2026-10-22-ucb-2026-20 2026-10-22 https://whattonoh.jp/articles/2026-10-23-kaisetsu-2 2026-10-23 https://whattonoh.jp/articles/2026-10-22-kaisetsu-2 2026-10-22 https://whattonoh.jp/articles/2026-10-22-her2 2026-10-22 https://whattonoh.jp/articles/2026-10-21-openai-orchestra-bio-rosalind 2026-10-21 https://whattonoh.jp/articles/2026-10-23-biontech-mrna 2026-10-23 https://whattonoh.jp/articles/2026-10-23-ips-car-nkt-jitc 2026-10-23 https://whattonoh.jp/articles/2026-10-22-mstoronto2026-iii 2026-10-22 https://whattonoh.jp/articles/2026-10-22-eu 2026-10-22 https://whattonoh.jp/articles/2026-10-21-3 2026-10-21 https://whattonoh.jp/articles/2026-10-21-idweek-2026-2 2026-10-21 https://whattonoh.jp/articles/2026-10-21-itp-btk-400mg 2026-10-21 https://whattonoh.jp/articles/2026-10-21-idweek-2026 2026-10-21 https://whattonoh.jp/articles/2026-10-21-hp-5120-ii 2026-10-21 https://whattonoh.jp/articles/2026-10-21-studio-398 2026-10-21 https://whattonoh.jp/articles/2026-10-21-heartseed-ips-iscience 2026-10-21 https://whattonoh.jp/articles/2026-10-21-gsk-b 2026-10-21 https://whattonoh.jp/articles/2026-10-22-fda-climara-pro-1 2026-10-22 https://whattonoh.jp/articles/2026-10-21-cagrisema-25-0-redefine-1 2026-10-21 https://whattonoh.jp/articles/2026-10-21-tezspire-3 2026-10-21 https://whattonoh.jp/articles/2026-10-21-uc-cd-2b-44 2026-10-21 https://whattonoh.jp/articles/2026-10-20-entyvio-verdict-70 2026-10-20 https://whattonoh.jp/articles/2026-10-20-j-j-48-2 2026-10-20 https://whattonoh.jp/articles/2026-10-20-gsk-msi-h-dmmr 2026-10-20 https://whattonoh.jp/articles/2026-10-19-kaisetsu 2026-10-19 https://whattonoh.jp/articles/2026-10-19-abbv-466-2a 2026-10-19 https://whattonoh.jp/articles/2026-10-21-kaisetsu 2026-10-21 https://whattonoh.jp/articles/2026-10-19-esmo2026-kras-g12c-iii 2026-10-19 https://whattonoh.jp/articles/2026-10-19-4-7-2 2026-10-19 https://whattonoh.jp/articles/2026-10-19-hd 2026-10-19 https://whattonoh.jp/articles/2026-10-19-ai-ep 2026-10-19 https://whattonoh.jp/articles/2026-10-19-esmo-2026-7 2026-10-19 https://whattonoh.jp/articles/2026-10-19-gsk-b7-h3-adc-ris-rez-ib-orr61 2026-10-19 https://whattonoh.jp/articles/2026-10-17-ibd-20-uegw-2026-2 2026-10-17 https://whattonoh.jp/articles/2026-10-17-fda 2026-10-17 https://whattonoh.jp/articles/2026-10-17-gsk-esmo-2026-20-3 2026-10-17 https://whattonoh.jp/articles/2026-10-17-ema-chmp-10-6 2026-10-17 https://whattonoh.jp/articles/2026-10-16-fda 2026-10-16 https://whattonoh.jp/articles/2026-10-16-kaisetsu-2 2026-10-16 https://whattonoh.jp/articles/2026-10-16-pwc-11 2026-10-16 https://whattonoh.jp/articles/2026-10-17-ema-chmp 2026-10-17 https://whattonoh.jp/articles/2026-10-16-fda-enspryng 2026-10-16 https://whattonoh.jp/articles/2026-10-16-ucb-zilbrysq-fda-gmg 2026-10-16 https://whattonoh.jp/articles/2026-10-16-hd-adiposeeds 2026-10-16 https://whattonoh.jp/articles/2026-10-16-esmo2026-iii 2026-10-16 https://whattonoh.jp/articles/2026-10-16-esmo2026-rcc-iii-2 2026-10-16 https://whattonoh.jp/articles/2026-10-16-mr 2026-10-16 https://whattonoh.jp/articles/2026-10-16-time-best-inventions-of-2026 2026-10-16 https://whattonoh.jp/articles/2026-10-16-ema-ras-150 2026-10-16 https://whattonoh.jp/articles/2026-10-16-chordia-2026-8-1-473 2026-10-16 https://whattonoh.jp/articles/2026-10-16-86 2026-10-16 https://whattonoh.jp/articles/2026-10-20-tak-881-2-3-50 2026-10-20 https://whattonoh.jp/articles/2026-10-20-nt1 2026-10-20 https://whattonoh.jp/articles/2026-10-17-mr 2026-10-17 https://whattonoh.jp/articles/2026-10-16-tak-881-pid-2-3 2026-10-16 https://whattonoh.jp/articles/2026-10-16-nt1 2026-10-16 https://whattonoh.jp/articles/2026-10-15-fda-10-28 2026-10-15 https://whattonoh.jp/articles/2026-10-14-kaisetsu-3 2026-10-14 https://whattonoh.jp/articles/2026-10-15-apac8-synmosa 2026-10-15 https://whattonoh.jp/articles/2026-10-15-3-part-a 2026-10-15 https://whattonoh.jp/articles/2026-10-16-j-j 2026-10-16 https://whattonoh.jp/articles/2026-10-16-3 2026-10-16 https://whattonoh.jp/articles/2026-10-14-3-affirm-24-35-8 2026-10-14 https://whattonoh.jp/articles/2026-10-13-mr-ai-ai 2026-10-13 https://whattonoh.jp/articles/2026-10-14-j-j-3-5-9 2026-10-14 https://whattonoh.jp/articles/2026-10-14-xfg 2026-10-14 https://whattonoh.jp/articles/2026-10-19-j-j-2026-4-1-1-34 2026-10-19 https://whattonoh.jp/articles/2026-10-19-j-j-26-1000-3-6 2026-10-19 https://whattonoh.jp/articles/2026-10-14-tegoprazan-nerd-iii-acg-2026 2026-10-14 https://whattonoh.jp/articles/2026-10-14-24-30-pfs-81-8 2026-10-14 https://whattonoh.jp/articles/2026-10-13-bms-ryz101-3-pfs-gep-nets 2026-10-13 https://whattonoh.jp/articles/2026-10-12-skyrizi-3-affirm-ibd-22 2026-10-12 https://whattonoh.jp/articles/2026-10-10-3 2026-10-11 https://whattonoh.jp/articles/2026-10-10-e7386-orr36-7 2026-10-11 https://whattonoh.jp/articles/2026-10-18-j-j-icotyde-2 2026-10-18 https://whattonoh.jp/articles/2026-10-10-refeel-pbc-biomed 2026-10-11 https://whattonoh.jp/articles/2026-10-09-16-5 2026-10-11 https://whattonoh.jp/articles/2026-10-11-biohaven-igg-asean 2026-10-11 https://whattonoh.jp/articles/2026-10-09-veeva-1-ai 2026-10-11 https://whattonoh.jp/articles/2026-10-09-her2 2026-10-11 https://whattonoh.jp/articles/2026-10-09-kaisetsu-2 2026-10-11 https://whattonoh.jp/articles/2026-10-08-temab-a-crc-nsclc-fda 2026-10-08 https://whattonoh.jp/articles/2026-10-08-kaisetsu 2026-10-08 https://whattonoh.jp/articles/2026-10-08-jcr-4iu 2026-10-08 https://whattonoh.jp/articles/2026-10-08-hd-iga-voyxact-sbla 2026-10-08 https://whattonoh.jp/articles/2026-10-08-kaisetsu-2 2026-10-08 https://whattonoh.jp/articles/2026-10-08-fda-csu-2 2026-10-08 https://whattonoh.jp/articles/2026-10-08-10-14-14-2 2026-10-08 https://whattonoh.jp/articles/2026-10-08-9 2026-10-08 https://whattonoh.jp/articles/2026-10-07-kaisetsu 2026-10-08 https://whattonoh.jp/articles/2026-10-06-intrabio-20-aqneursa 2026-10-06 https://whattonoh.jp/articles/2026-10-08-14 2026-10-08 https://whattonoh.jp/articles/2026-10-08-1-4-400 2026-10-08 https://whattonoh.jp/articles/2026-10-08-amed-grit-15 2026-10-08 https://whattonoh.jp/articles/2026-10-08-monzosertib 2026-10-08 https://whattonoh.jp/articles/2026-10-18-j-j-2 2026-10-18 https://whattonoh.jp/articles/2026-10-14-70 2026-10-14 https://whattonoh.jp/articles/2026-10-18-ucb-eadv2026-hs3 2026-10-18 https://whattonoh.jp/articles/2026-10-07-gl-a-1 2026-10-08 https://whattonoh.jp/articles/2026-10-07-1 2026-10-08 https://whattonoh.jp/articles/2026-10-18-j-j-imaavy-gmg-2-mgfa-aanem-15 2026-10-18 https://whattonoh.jp/articles/2026-10-19-iga 2026-10-19 https://whattonoh.jp/articles/2026-09-09-49-4-29 2026-09-09 https://whattonoh.jp/articles/2026-09-09-otc-9-3 2026-09-09 https://whattonoh.jp/articles/2026-09-08-ai 2026-09-08